Ruxolitinib: Landmark vitiligo cream targets immune cells that disrupt pigmentation
Vitiligo involves paler, less-pigmented skin patches Getty Images A first-of-its-kind cream that targets the underlying cause of vitiligo will be made available on the National Health Service in England. In clinical trials, the cream significantly increased pigmentation in the white skin patches caused by the condition, but the treatment has previously been described as controversial,…
